Cardiac Pacemaker Market – Insights
Cardiac pacemaker is a medical device placed in the chest to control abnormal heart rhythm of the patient by using electrical pulses, which prompt the heart to contract and pump blood. Pacemakers have ability to monitor and record heart's rhythm and electrical activity. Cardiac pacemaker is composed of a small titanium encased pulse generator, which contains a lithium battery and electrical circuitry attached to one, two, or three leads, which are inserted into the heart. Pacemaker pulse generators should be checked twice to thrice a year and must be replaced every five to ten years. The technical advantages of lithium iodine battery in terms of its longevity, adaptable shapes and sizes, light weight, no gas generation, corrosion resistance, and excellent current drain characteristics makes the cardiac pacemakers suitable to last as long as the expected lifetime.
The global cardiac pacemaker market was valued at US$ 5,972.2 million in 2017, and is expected to witness a CAGR of 7.3% over the forecast period (2018–2026).
Figure 1. Global Cardiac Pacemaker Market value Analysis (US$ Mn) and Forecast and Absolute $ Opportunity
Cardiac Pacemaker Market Dynamics
Increasing incidence of cardiovascular diseases worldwide is fueling growth of the cardiac pacemaker market. According to the Centre for Disease Control and Prevention (CDC) foundation, 2015, around 800,000 Americans die due to stroke and other cardiovascular diseases. Moreover, increasing number of geriatric population across the various regions worldwide along with high prevalence of heart disease is expected to propel demand for implantable cardiac pacemakers in the near future. According to the data published in the Journal of the Formosan Medical Association, in November 2016, around half of the world population living in Asia is geriatric population and it is growing at faster rate, which is increasing burden of Atrial Fibrillation (AF) in Asia. According to the same source, in 2050, around 72 million people are projected to suffer from AF in Asia, which is expected to be more than double the combined numbers of patients from Europe and the U.S.
Introduction of advance technology such as wireless and automated pacemaker monitoring pacemakers are gaining significant traction among healthcare providers. Moreover, increasing adoption of advanced technologies in cardiac pacemakers such as MRI safe-pacemakers, pacemakers with improved battery life, delay the progression of persistent Atrial Fibrillation (AF) in patients suffering from bradycardia and wireless automated technologies have gained significant traction among cardiac pacemakers market players, which is expected to drive growth of cardiac pacemakers market. For instance, in February 2017, Abbott received the Food and Drug Administration (FDA) approval for its MR-conditional labeling for both of its products i.e. Assurity MRI pacemaker and the Tendril MRI pacing lead. However, installation of pacemakers is associated with risk of developing infections in cardiac patients, which may restrain market growth. Pacemaker surgery can led to various complications such as swelling, bruising, bleeding, or infection at the of area of pacemaker implantation leading to blood vessel or nerve damage, which may reduce the adoption of cardiac implants in patients, in turn negatively impacting market growth.
Cardiac Pacemaker Market Regional Outlook
On the basis of geography, the global cardiac pacemaker market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to hold dominant position in this market, owing to increasing prevalence of heart diseases and adoption of technologically advanced products. Moreover, factors such as improved healthcare facilities and better reimbursement scenario are also driving growth of the cardiac pacemakers market in this region. In March 2017, Medtronic issued Medicare reimbursement for the first leadless cardiac pacemaker Mica Trans catheter Pacing System (TPS), which is available in the U.S. Asia Pacific is projected to witness significant growth in market over the forecast period, owing to presence of large patient population, increasing healthcare expenditures in emerging economies such as India and China which, and growing healthcare sector. Emerging economies such as Asia Pacific and Latin America has huge potential for market growth and is likely to be the fastest growing region throughout the forecast period.
Major companies operating in the cardiac pacemaker market include Medtronic Plc., BIOTRONIK, Inc., Boston Scientific Corporation, Abbott Laboratories, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC, and Qinming Medical, and Cordis Inc.
Pacemaker is a device implanted on either (left or right) side of the chest and is connected with heart through pacing wires (also called as lead). It continuously monitors the heart rate and in case it detects slow heart rate, the device sends out electrical pulse to bring the heart rate to normal. Development of new products in pacemakers such as multi-chamber, two and three-chamber pacemakers, magnetic resonance imaging (MRI) compatible pacemakers, and leadless pacemaker has aided in greater adoption of this technology. This has led to growth of the market.
New product launches by market players, owing to technological advancement in cardiac pacemakers are expected to drive growth of the market. Key manufacturers are engaged in launching more compact and efficient pacemaker device, which allows better control of abnormal heart rhythm along with additional specifications such as blood temperature monitor and breathing rate. For instance, in May 2016, Biotronik launched CardioMessenger Smart, portable monitoring device in the U.S. This system is about the size of a modern smartphone used to keep pacemaker, Implantable Cardioverter Defibrillator (ICD) and Insertable Cardiac Monitor (ICM) patients connected to their physician remotely. This CardioMessenger Smart helps to ensure patient compliance and the consistent transmission of data necessary for physicians to identify and prevent potential cardiac events. Moreover, high prevalence of cardiovascular disease is the major factor driving growth of global cardiac pacemaker market over the forecast period. As per statistics published by the World Health Organization (WHO), globally, an alarmingly high number of deaths resulted from cardiovascular disease in 2012, resulting in 31.0% or equating to 17.5 million lives. Among these, around 40.0% and 38.0% deaths were caused by coronary heart disease and stroke, respectively.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 35 market data tables and 44 figures on "Cardiac Pacemaker Market” - Global forecast to 2026”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.